InMode (INMD) Capital Expenditures Growth (1y) (2019 - 2026)
InMode (INMD) Capital Expenditures Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | -1.00% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 10.38% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 24.20% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 35.70% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | -9.99% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 16.28% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | -4.32% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | -6.52% |
| 10 | InMode | 921.69 Mn | 506.52 Mn | 71.52 Mn | 3.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -102.35% |
| Dec 31, 2025 | -128.21% |
| Sep 30, 2025 | -74.03% |
| Jun 30, 2025 | 10.98% |
| Mar 31, 2025 | 24.11% |
| Dec 31, 2024 | -1,014.29% |
| Sep 30, 2024 | 48.32% |
| Jun 30, 2024 | -26.80% |
| Mar 31, 2024 | 67.16% |
| Dec 31, 2023 | 93.60% |
| Sep 30, 2023 | 61.50% |
| Jun 30, 2023 | 65.42% |
| Mar 31, 2023 | -14.05% |
| Dec 31, 2022 | -80.22% |
| Sep 30, 2022 | -52.36% |
| Jun 30, 2022 | -65.98% |
| Mar 31, 2022 | -81.21% |
| Dec 31, 2021 | -420.00% |
| Sep 30, 2021 | -146.60% |
| Jun 30, 2021 | -49.56% |